Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.30 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6331251 | 0.97 | ALDH1A1 (0.41) | ALDH1A1TSHRCA1CA2CA4 | |
| SCHEMBL6328019 | 0.97 | ALDH1A1 (0.41) | ALDH1A1TSHRCA1CA2CA4 | |
| SCHEMBL16617790 | 0.88 | CTDSP1 (0.39) | ALDH1A1TSHRCA1CA2CA4 | |
| SCHEMBL6355777 | 0.83 | CA1 (0.36) | ALDH1A1TSHRCA1CA2CA4 | |
| SCHEMBL8254998 | 0.81 | ALDH1A1 (0.39) | ALDH1A1TSHRHSD17B10CTDSP1HSD11B1 | |
| SCHEMBL16625925 | 0.79 | TSHR (0.41) | ALDH1A1TSHRPKMCTDSP1HSD11B1 | |
| SCHEMBL810971 | 0.77 | CA1 (0.36) | ALDH1A1TSHRCA1CA2CA4 | |
| SCHEMBL16625923 | 0.77 | TSHR (0.38) | ALDH1A1TSHRCA1CA2CA4 | |
| SCHEMBL6346433 | 0.77 | CA1 (0.42) | ALDH1A1TSHRCA1CA2CA4 | |
| SCHEMBL16625922 | 0.75 | TSHR (0.38) | TSHRHSD17B10CTDSP1HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1260572-B1 | High-purity cyclopentanone derivatives, process for preparing same, and perfume composition | ZEON CORP (JP) | 2006-05-03 | — | — | EP | claimed |
| US-6653276-B2 | A cyclopentanone or cyclopentanol compound having 2,5-dicyclopentylidene substituents, 2,5- dicyclopentyl substituents or 2-cyclopentylidene-5-cyclopentyl substituents; useful as perfume emitting floral fragrance | ZEON CORPORATION (JP) | 2003-11-25 | — | — | US | claimed |
| US-20030012799-A1 | High-purity cyclopentane compound having oxygen-containing group, process for preparing same, and perfume composition | ZEON CORPORATION (JP) | 2003-01-16 | — | — | US | claimed |
| EP-1260572-A1 | High-purity cyclopentanone derivatives, process for preparing same, and perfume composition | Zeon Corporation (JP) | 2002-11-27 | — | — | EP | claimed |
| CN-112062649-B | Alkyl-substituted polycyclic biomass high-density aviation fuel and preparation method thereof | 西安交通大学 | 2021-05-28 | — | — | CN | disclosed |
| CN-112062649-A | Alkyl-substituted polycyclic biomass high-density aviation fuel and preparation method thereof | 西安交通大学 | 2020-12-11 | — | — | CN | disclosed |
| EP-1260572-B1 | High-purity cyclopentanone derivatives, process for preparing same, and perfume composition | ZEON CORP (JP) | 2006-05-03 | — | — | EP | disclosed |
| US-6653276-B2 | A cyclopentanone or cyclopentanol compound having 2,5-dicyclopentylidene substituents, 2,5- dicyclopentyl substituents or 2-cyclopentylidene-5-cyclopentyl substituents; useful as perfume emitting floral fragrance | ZEON CORPORATION (JP) | 2003-11-25 | — | — | US | disclosed |
| US-6653276-B2 | A cyclopentanone or cyclopentanol compound having 2,5-dicyclopentylidene substituents, 2,5- dicyclopentyl substituents or 2-cyclopentylidene-5-cyclopentyl substituents; useful as perfume emitting floral fragrance | ZEON CORPORATION (JP) | 2003-11-25 | — | — | US | disclosed |
| US-20030012799-A1 | High-purity cyclopentane compound having oxygen-containing group, process for preparing same, and perfume composition | ZEON CORPORATION (JP) | 2003-01-16 | — | — | US | disclosed |
| US-20030012799-A1 | High-purity cyclopentane compound having oxygen-containing group, process for preparing same, and perfume composition | ZEON CORPORATION (JP) | 2003-01-16 | — | — | US | disclosed |
| EP-1260572-A1 | High-purity cyclopentanone derivatives, process for preparing same, and perfume composition | Zeon Corporation (JP) | 2002-11-27 | — | — | EP | disclosed |
| EP-1260572-A1 | High-purity cyclopentanone derivatives, process for preparing same, and perfume composition | Zeon Corporation (JP) | 2002-11-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030012799-A1 | High-purity cyclopentane compound having oxygen-containing group, process for preparing same, and perfume composition | DHPS, DOHH, PORCN | ALDH1A1 1835/4885TSHR 4881/4885CA1 3486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.